TG Forum Logo TG Forum Logo

Plozasiran in severe hypertriglyceridaemia: Update

You are here: Home > Expert Meetings


Daniel Gaudet, ECOGENE-21, Université de Montréal, Canada, highlights results from clinical trials supporting the efficacy and safety of plozasiran in hypertriglyceridaemia, with sustained apoCIII and TG reductions and fewer acute pancreatitis events.

Please login or create a FREE account to view this content

View more presentations from this meeting >

Educational Supporters of the 12th Closed Scientific Expert Meeting of the Editorial Board

Principal supporters:

Guest supporters:

Kowa logo
Pfizer logo

Educational partners and supporters

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Arrowhead Pharmaceuticals
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Ionis Logo
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Kowa Logo
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Recordati
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Sobi